iRhythm Technologies, Inc. (IRTC) vs Pulse Biosciences, Inc. (PLSE)

A side-by-side comparison of iRhythm Technologies, Inc. and Pulse Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IRTC vs PLSE

growth of $100 · dividends reinvested · last 10y
IRTC +318.8% (+15.4%/yr)PLSE +769.2% (+24.1%/yr)PLSE compounded faster over this window
02004006008001kStart $10020182020202220242026$419$869
IRTC PLSE

IRTC vs PLSE: by the numbers

  • •IRTC is the larger company ($3.52B vs $3.42B market cap).
  • •Both run net losses; IRTC's is the smaller (-1.69% vs -6755.78% net margin).

Metrics side by side

Valuation

MetricIRTCPLSE
P/S ratio4.272883.45
P/B ratio18.9434.34
EV / EBITDA286.34N/A
FCF yield1.11%N/A

Profitability

MetricIRTCPLSE
Gross margin71.45%-360.00%
Operating margin-1.17%-21982.57%
Net margin-1.69%-6755.78%
ROE-7.50%-80.46%
ROIC-1.07%-79.40%

Growth (annualized)

MetricIRTCPLSE
Revenue CAGR (5Y)21.93%N/A
Total return CAGR (5Y)12.95%19.76%

Frequently asked

How have IRTC and PLSE total returns compared?
Over the past 5 years, IRTC delivered 12.95% and PLSE delivered 19.76% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.